Search

everythinglearnresearchcommunity

for

Search:↓

LED light therapy may help hair growth by activating certain cell pathways.

Some alternative treatments for hair loss might work, but more research is needed.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Stem cell therapy may help treat tough hair loss cases.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The hepatitis B vaccine did not cause hair loss in the tested mice.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A genetic marker linked to a type of hair loss was found in most patients studied.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

A patient with a skin condition had unusual scarring hair loss but improved with treatment.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Platelet rich plasma is an effective treatment for alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.